Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CEO Christopher Richard Anzalone sold 13,445 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $67.66, for a total transaction of $909,688.70. Following the sale, the chief executive officer directly owned 3,818,512 shares of the […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CEO Christopher Richard Anzalone sold 54,298 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $62.58, for a total transaction of $3,397,968.84. Following the transaction, the chief executive officer owned 3,916,957 shares in the company, […]